Swiss drugmaker Roche has entered a partnership with Atavistik Bio potentially worth nearly $2 billion, including milestone payments, to develop oral treatments for cardiovascular, kidney and metabolic diseases. The deal includes $70 million upfront with an additional $1.9 billion in potential milestone payments.
Russian President Vladimir Putin signed a decree placing the Russian subsidiaries of Swiss food giant Nestlé and French retailers Auchan and Leroy Merlin under temporary state administration, the latest move against Western companies operating in Russia.
Swiss Bitcoin Pay, a non-custodial bitcoin payment processor based in Neuchâtel, shut down its entire server infrastructure on Monday after discovering a malicious intruder had gained access to its internal systems. The company warned that customer email addresses, Bitcoin addresses, IBANs, transaction history, and hashed passwords may have been compromised.
Bitcoin Suisse announced plans to eliminate up to 60 of its 120 positions in Switzerland and close its Copenhagen development site as part of a strategic reorganization to expand international operations. The crypto financial services firm, founded in Zug in 2013, is shifting operations abroad.
Major Novartis shareholder Artisan Partners is demanding board changes and improved dealmaking after the Swiss drugmaker's shares suffered a record fall following three consecutive major clinical trial failures, raising questions about corporate governance and R&D strategy.
The CEO of Swiss pharmaceutical company Sandoz cautioned that President Donald Trump's threatened tariffs on generic drugs would ultimately be paid by American patients, as manufacturers could pass increased costs onto consumers.
The CEO of Swiss pharmaceutical company Sandoz cautioned that President Donald Trump's threatened tariffs on generic drugs would ultimately be paid by American patients, as manufacturers could pass increased costs onto consumers.
Swiss pharmaceutical giant Novartis saw its stock drop as much as 10% following the failure of an experimental neuromuscular treatment in a late-stage clinical trial. The setback comes just days after another high-profile trial failure in heart disease, marking the company's third recent drug development disappointment.
Nine Swiss financial institutions including UBS, SIX, and TWINT launched a formal pilot test of CHFD, a stablecoin pegged to the Swiss franc, on September 8. The participants plan to test various use cases including automated transactions and settlement between financial institutions.
Swiss banking giant UBS will require all graduate and intern applicants to its Global Banking and Markets division to demonstrate AI skills in interviews starting in 2027, marking a shift from workforce reduction concerns to mandatory AI competency requirements in banking recruitment.
The Swiss government recommended that parliament reject an initiative aimed at blocking a new agreement between Switzerland and the European Union. The deal would represent the biggest overhaul in bilateral economic relations in a generation.
Canada imposed sanctions on UAE-based Streit Group, a Canadian-owned armored vehicle manufacturer, for supplying military equipment to Russia's National Guard used in the war against Ukraine. The sanctions complete a four-nation effort alongside Ukraine, the EU, and Switzerland.
President Paul Biya, the world's oldest head of state, has ordered a major military reshuffle through presidential decrees, replacing commanders in four of Cameroon's five joint military regions and promoting the Presidential Guard chief to brigadier general. The moves come as Biya has not been seen publicly for nearly two months, reportedly staying in Switzerland, sparking growing unease about his prolonged absence.
Swiss generic drugmaker Sandoz has reached a settlement agreement to pay $450 million to 43 US states and territories to resolve antitrust litigation alleging anti-competitive conduct and price manipulation in the generic medicines market. The settlement includes no admission of wrongdoing and will not affect the company's financial guidance.
Switzerland's SRO (Self-Regulatory Organization) system, which allows crypto firms to join private supervisory bodies for anti-money laundering compliance, is being highlighted as a model for enabling faster market entry while maintaining regulatory oversight.
Swiss technology innovation center CSEM and biosensing technology company B-Secur announced a partnership to integrate clinically-validated heart monitoring capabilities into health wearables, combining CSEM's PPG-based vital signs monitoring expertise with B-Secur's biosensing technology.
FINMA-regulated Swiss digital-asset bank AMINA is evaluating multiple paths to go public, including an IPO, SPAC merger, or reverse merger, with financial services firm Cantor Fitzgerald providing advisory services. The bank states its immediate priority remains securing strategic capital for growth.
Samsung Biologics announced an all-cash tender offer to acquire Switzerland's PolyPeptide Group AG for CHF 1.46 billion ($1.8B), at CHF 44.31 per share — a 6.1% premium to last close and ~40% to the April 10, 2026 undisturbed price, marking South Korea's largest biopharma acquisition.
Swiss pharmaceutical company Novartis has agreed to acquire UK-based biotechnology firm Myricx Bio for up to $1.5 billion, gaining access to experimental antibody-drug conjugates (ADCs) designed to deliver cancer treatments directly to tumors. The deal is expected to close in the second half of 2026.
A breakaway group of traditionalist Catholics consecrated four bishops without papal consent in Écône, Switzerland, directly defying Pope Leo XIV's warnings and triggering automatic excommunications. The Society's actions represent the first major crisis of Pope Leo XIV's papacy and raise the specter of formal schism within the Catholic Church.
Multiple oil tankers sailed through the Strait of Hormuz on Thursday using a UN-recommended route despite Iranian threats, as oil prices dropped to pre-conflict levels following US-Iran talks in Switzerland that resulted in partial sanctions relief. One cargo ship was reportedly hit by a projectile during the passage.
A severe heatwave gripping Western Europe has caused at least 212 excess deaths in Spain since Sunday, with the UK and Switzerland recording their hottest-ever June temperatures. At least 101 million Europeans are affected by the extreme heat, which has also caused power outages and health emergencies across multiple countries.
Technical negotiations between Iran and the United States in Switzerland have concluded successfully, with both sides expressing optimism and reaching an agreement to release $12 billion in frozen Iranian assets. The talks, aimed at implementing a ceasefire and ending hostilities, were followed by cyber attacks on Iranian state-owned banks.
U.S. Vice President JD Vance met with Iranian officials in Switzerland to negotiate a permanent end to the war between the U.S., Israel and Hezbollah that began in late February 2026, while Lebanon discusses deconfliction mechanisms and northern Israeli communities remain largely deserted.
Vice President JD Vance said Monday that Iran has agreed to allow nuclear inspectors back into the country following talks with senior Iranian officials in Switzerland, describing the discussions as creating a 'good foundation' for a final deal to resolve the conflict between the two nations.
Israel and Hezbollah are holding to a tense ceasefire with Israeli troops restricted to defensive positions in Lebanon, while Israeli officials express concern that new U.S.-Iran understandings reached in Switzerland are legitimizing Iranian influence and constraining Israel's operational freedom in the region.
The United States has authorized Iranian oil sales through August, easing decades-old sanctions following productive negotiations in Switzerland. The move comes as part of a broader push toward a final peace deal involving nuclear inspections and free transit through the Strait of Hormuz.
Vice President JD Vance met with senior Iranian officials in Switzerland, describing the talks as laying a "good foundation" for a deal to end hostilities. However, Iran disputed Vance's claim about allowing nuclear inspectors back, while President Trump threatened further attacks even as his administration waived sanctions and pursued financial concessions.
Vice President JD Vance conducted high-level negotiations with Iran in Switzerland following an apparent conflict, claiming progress toward peace while President Trump simultaneously issued threats that disrupted the talks. The negotiations have ended with technical discussions continuing, as both Democratic and Republican lawmakers express skepticism about any provisional deal.
The United States and Iran have agreed to a ceasefire and 'road map' for negotiations following nearly four months of conflict, with Pakistan and Qatar mediating talks in Switzerland. The agreement includes partial lifting of U.S. sanctions on Iranian oil but leaves unresolved questions about Iran's nuclear program.
High-level negotiations in Switzerland aimed at ending the Iran-US conflict faced immediate turmoil as Iranian negotiators walked out in protest of President Trump's threats to bomb Iran, even as Vice President Vance offered diplomatic overtures. The talks, which involve efforts to resolve the Lebanon war and reopen the Strait of Hormuz, are expected to continue at lower levels despite the tense start.
High-level negotiations between the United States and Iran concluded in Switzerland after the first round of talks aimed at achieving a permanent end to their conflict and cementing a ceasefire. Mediators Pakistan and Qatar reported "encouraging progress" and announced that technical-level discussions will continue through the week, despite tensions from President Trump's renewed threats of strikes and Iran's closure of the Strait of Hormuz.
Vice President JD Vance postponed his trip to Geneva for nuclear negotiations with Iran while sharply criticizing Israeli leaders for their reaction to a preliminary U.S.-Iran agreement. The Trump administration deal, which leaves many core issues unresolved, has drawn strong opposition from Israel.
Qatar secured their first-ever World Cup point with a dramatic 95th-minute equalizer against Switzerland, but the match was overshadowed by a technical failure in FIFA's semi-automated offside system that prevented officials from releasing VAR images of a controversial penalty decision involving Switzerland's Remo Freuler.
Switzerland is holding a referendum on June 14, 2026, on whether to cap its population at 10 million people, a proposal that has drawn comparisons to Brexit and could significantly impact the country's relationship with the European Union. The Alpine nation's population currently stands at approximately 9.1 million, having grown 23% since 2002.
Swiss pharmaceutical giant Roche has signed an exclusive licensing and collaboration agreement with Nurix Therapeutics for bexobrutinib, a protein degrader drug targeting B cell malignancies and blood cancers. The deal value is reported as up to $2.3 billion by one source and up to $3 billion by another.
Zurich-based Sygnum Bank has connected its regulated cryptocurrency services directly to BancaStato's online banking system, enabling the Swiss cantonal bank's clients in Ticino to buy, hold, and sell digital assets including Bitcoin, Ethereum, Litecoin, and Solana through their existing banking interface.
Swiss Financial Market Supervisory Authority (FINMA) approved SIX's plan to merge its digital central securities depository (SIX Digital Exchange) into its traditional CSD, SIX SIS, consolidating digital and traditional securities infrastructure.
A luxury cruise ship experiencing a hantavirus outbreak has been permitted by Spanish authorities to sail from Cape Verde to the Canary Islands, with three infected or suspected patients evacuated and nearly 150 people remaining isolated in their cabins. Swiss authorities confirmed a third case linked to the vessel.
Swiss drugmaker Roche presented latest clinical trial data for its experimental multiple sclerosis drug at a major conference, setting the stage for regulatory approval submissions, though safety questions remain under scrutiny.
President Trump signed an executive order imposing up to 100% tariffs on certain branded pharmaceutical imports unless drugmakers negotiate pricing agreements with his administration, marking a major escalation in his drug pricing strategy.
